News & Events
The latest developments in medical and technological advances in health and SCHILLER’s participation in various events.
Resistant hypertension (or refractory arterial hypertension) is defined as blood pressure that remains above the target despite the use of
The 2023 ACR Guideline for the Detection and Monitoring of Interstitial Lung Disease (ILD) provides evidence-based recommendations to support early
Occupational lung diseases represent a significant but often underdiagnosed health risk among workers exposed to airborne pollutants in industrial, agricultural,
The diagnosis of asthma is an urgent need for two main reasons. The first is that it is estimated to
Spirometry is fundamental for lung function assessment of overall pulmonary function. It allows analyzing the impact on lung function caused
When Alfred Schiller founded SCHILLER AG in Zurich, Switzerland, in 1974, he did so with the fervent desire to save
Ambulatory monitoring devices, such as Holter and ABPM devices, collect and analyze long-term data. This facilitates the early detection of
To support better diagnosis and risk assessment in patients with coronary artery disease, the American College of Cardiology (ACC) Foundation—together
In the fascinating world of cardiology, continuous research drives significant advancements that shape the future of cardiovascular healthcare. The year